World

Analysis: Sales of first big Covid-19 drug, remdesivir, may disappoint

The World Health Organization on Thursday said its international trial of Covid-19 therapies found that remdesivir did not have a substantial effect on patients’ length of hospital stay or chances of survival. Analysis: Sales of first big Covid-19 drug, remdesivir, may disappoint
An ampule of Gilead Sciences Covid-19 antiviral remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, on April 8, 2020.  Ulrich Perrey/Pool via Reuters
bookmark
Reuters
Published at : October 16, 2020
Updated at : October 16, 2020 16:54

×
Top